p53 Gene Therapy in Treatment of Diabetes Concurrent With Hepatocellular Carcinoma
Phase 2
- Conditions
- DiabetesHCC
- Interventions
- Drug: p53 gene therapyDrug: Trans-catheter embolization
- First Posted Date
- 2015-09-28
- Last Posted Date
- 2015-09-28
- Lead Sponsor
- Shenzhen SiBiono GeneTech Co.,Ltd
- Target Recruit Count
- 40
- Registration Number
- NCT02561546
- Locations
- π¨π³
first affiliated hospital in Dalian University, Dalian, Liaoning, China
Trans-catheter Arterial Embolization Combined With p53 Gene Therapy for Treatment of Advanced Hepatocellular Carcinoma
Phase 2
- Conditions
- Advanced Hepatocellular Carcinoma (HCC)
- Interventions
- Drug: TAE plus P53 geneOther: TAE
- First Posted Date
- 2015-07-27
- Last Posted Date
- 2015-07-27
- Lead Sponsor
- Shenzhen SiBiono GeneTech Co.,Ltd
- Target Recruit Count
- 60
- Registration Number
- NCT02509169
- Locations
- π¨π³
first affiliated hospital in Dalian University, Dalian, Liaoning, China
p53 Gene in Treatment of Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer
Phase 2
- Conditions
- Ovarian Epithelial CancerFallopian Tube CancerPrimary Peritoneal Cancer
- Interventions
- First Posted Date
- 2015-05-06
- Last Posted Date
- 2015-05-06
- Lead Sponsor
- Shenzhen SiBiono GeneTech Co.,Ltd
- Target Recruit Count
- 100
- Registration Number
- NCT02435186
- Locations
- π¨π³
xijing hospital in China Medical University, Shenyang, Liaoning, China
P53 Gene Combined With Radio- and Chemo-therapy in Treatment of Unresectable Locally Advanced Head and Neck Cancer
Phase 2
- Conditions
- Advanced Head and Neck Cancer
- Interventions
- First Posted Date
- 2015-04-29
- Last Posted Date
- 2015-04-29
- Lead Sponsor
- Shenzhen SiBiono GeneTech Co.,Ltd
- Target Recruit Count
- 60
- Registration Number
- NCT02429037
- Locations
- π¨π³
Jiangsu cancer hospital, Nanjing, Jiangsu, China
Recombinant Adenoviral Human p53 Gene in Treatment of Malignant Pleural Effusion
Phase 2
- Conditions
- Malignant Pleural Effusion
- Interventions
- First Posted Date
- 2015-04-29
- Last Posted Date
- 2015-04-29
- Lead Sponsor
- Shenzhen SiBiono GeneTech Co.,Ltd
- Target Recruit Count
- 90
- Registration Number
- NCT02429726
- Locations
- π¨π³
The First Affiliated Hospital of Xi'an Jiao Tong University, Xian, Shanxi, China
Trans-catheter Chemo-embolization Combined With rAd-p53 Gene Injection in Treatment of Advanced Hepatocellular Carcinoma
Phase 2
- Conditions
- Advanced Adult Hepatocellular Carcinoma
- Interventions
- First Posted Date
- 2015-04-17
- Last Posted Date
- 2015-04-17
- Lead Sponsor
- Shenzhen SiBiono GeneTech Co.,Ltd
- Target Recruit Count
- 120
- Registration Number
- NCT02418988
- Locations
- π¨π³
Xijing Hospital of the Fourth Military Medical University, Xi An, Shanxi, China
Surgery Combined With rAd-p53 Gene in Treatment Advanced Non-small-cell Carcinoma
Phase 2
- Conditions
- Non-small Cell Lung Cancer
- Interventions
- Procedure: SurgeryDrug: Surgery combined with rAd-p53 gene therapy
- First Posted Date
- 2012-04-10
- Last Posted Date
- 2012-06-28
- Lead Sponsor
- Shenzhen SiBiono GeneTech Co.,Ltd
- Target Recruit Count
- 120
- Registration Number
- NCT01574729
- Locations
- π¨π³
Institute of Surgery Research, Daping Hospital, Third Military Medical University, Chongqing, Chongqing, China
rAd-p53 Gene Therapy for Advanced Malignant Thyroid Tumors
Phase 4
- Conditions
- Advanced Malignant Thyroid Tumors
- Interventions
- Drug: rAd-p53 geneProcedure: surgeryDrug: p53 gene therapyRadiation: p53 gene therapy with radioactive iodine
- First Posted Date
- 2009-05-14
- Last Posted Date
- 2012-04-09
- Lead Sponsor
- Shenzhen SiBiono GeneTech Co.,Ltd
- Target Recruit Count
- 600
- Registration Number
- NCT00902122
- Locations
- π¨π³
West China Hospital, Sichuan University, Chengdu, Sichuan, China
rAd-p53 Gene Therapy for Advanced Oral and Maxillofacial Malignant Tumors
Phase 4
- Conditions
- Advanced Oral and Maxillofacial Malignant Tumors
- Interventions
- Drug: p53 gene with surgeryProcedure: surgeryDrug: p53 with chemotherapyDrug: p53 gene therapy
- First Posted Date
- 2009-05-14
- Last Posted Date
- 2012-04-09
- Lead Sponsor
- Shenzhen SiBiono GeneTech Co.,Ltd
- Target Recruit Count
- 600
- Registration Number
- NCT00902083
- Locations
- π¨π³
West China Hospital, Sichuan University, Chengdu, Sichuan, China
p53 Gene Therapy for Head and Neck Malignant Tumors in Advanced Stage
Phase 4
- Conditions
- Neoplasms
- Interventions
- Radiation: radiotherapyDrug: chemotherapy plus p53Drug: chemotherapy
- First Posted Date
- 2009-05-06
- Last Posted Date
- 2012-04-09
- Lead Sponsor
- Shenzhen SiBiono GeneTech Co.,Ltd
- Target Recruit Count
- 1200
- Registration Number
- NCT00894153
- Locations
- π¨π³
Department of oral and maxillofacial surgery, Huaxi university of medical science, Chendu, Shichuan, China
Β© Copyright 2025. All Rights Reserved by MedPath